Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2005
07/05/2005US6914069 Pharmaceutically active compounds and methods of use
07/05/2005US6914062 Pyrazinone derivatives
07/05/2005US6914058 1-(p-(thiomorpholino)phenyl)-1,2,3-triazole derivatives
07/05/2005US6914054 Treatment with a 1' 2' and/or 3' nucleoside or a pharmaceutically acceptable salt or prodrug; nontoxic
07/05/2005CA2309485C New 4-arylpiperidine derivatives for the treatment of pruritus
07/05/2005CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes
07/05/2005CA2064382C Pharmaceutical compounds
06/2005
06/30/2005WO2005058885A2 Piperidine derivatives and their use as glycine transporter inhibitors
06/30/2005WO2005058883A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists
06/30/2005WO2005058882A1 Compounds having morpholinyl and piperidinyl groups for use as glyt1 and glyt2 inhibitors
06/30/2005WO2005058881A1 Chemical compounds
06/30/2005WO2005058880A1 Doxepin analogs and methods of use thereof
06/30/2005WO2005058879A1 Preventive and/or remedy for exudative otitis media
06/30/2005WO2005058878A1 Preventive and/or remedy for dysmenorrhea
06/30/2005WO2005058876A1 Pyrazine derivatives as effective compounds against infectious diseases
06/30/2005WO2005058874A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
06/30/2005WO2005058870A1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
06/30/2005WO2005058869A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
06/30/2005WO2005058865A2 Assay for entactogens
06/30/2005WO2005058864A1 Assay for entactogens
06/30/2005WO2005058858A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
06/30/2005WO2005058857A1 Tetronic and tetramic acids as inhibitors of beta-secrease
06/30/2005WO2005058837A1 Benzazepine derivatives as histamine h3 antagonists
06/30/2005WO2005058836A1 Insecticidal spiroindane derivatives
06/30/2005WO2005058834A2 Quinolines useful in treating cardiovascular disease
06/30/2005WO2005058833A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides
06/30/2005WO2005058830A1 Novel herbicides
06/30/2005WO2005058824A2 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprote in b
06/30/2005WO2005058822A1 Substituted amino-cycloalkanes
06/30/2005WO2005058311A1 Heterocyclic aspartyl protease inhibitors
06/30/2005WO2005058037A1 Picolinylpyrazoles as herbicides
06/30/2005WO2005058035A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides
06/30/2005WO2005032493A8 Amide compounds as ion channel ligands and uses thereof
06/30/2005WO2005032484A3 Alkoxy substituted imidazoquinolines
06/30/2005WO2004087148A9 Remedy and/or preventive for lung diseases
06/30/2005US20050143447 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound
06/30/2005US20050143446 Compounds for use as antigrowth agents or antitumor agents and with solvents
06/30/2005US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors
06/30/2005US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases
06/30/2005US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
06/30/2005US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/30/2005US20050143418 Pesticidal heterocycles
06/30/2005US20050143405 Dipeptidyl peptidase inhibitors that lower plasma glucose; treatment and prophylaxis of diabetes, non-insulin dependent diabetes; 2-amino-3aminomethyl-4-phenylpyridines
06/30/2005US20050143401 Anticancer agents; (4-(3-Fluorobenzyloxy)-3-chlorophenyl)-(6-(2-((2-methanesulphonyl-ethylamino)ethyl)-thiazol-4-yl)-quinazolin-4-yl)-amine
06/30/2005US20050143387 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints
06/30/2005US20050143373 Benzodioxole derivatives
06/30/2005US20050143372 Compounds, pharmaceutical compositions and methods of use therefor
06/30/2005US20050143348 Doxepin analogs and methods of use thereof
06/30/2005US20050143316 Hepatitis C virus inhibitors
06/30/2005US20050142614 Methods for ligand discovery
06/30/2005US20050142542 Absobers materials used for removal or reduction of microbiocides from body fluids such as blood; filtration
06/30/2005US20050142188 Pellets having a core coated with an antifungal and a polymer
06/30/2005US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders
06/30/2005CA2551944A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists
06/30/2005CA2550074A1 Novel chelating agents and highly luminescent and stable chelates and their use
06/30/2005CA2549111A1 Doxepin analogs and methods of use thereof
06/30/2005CA2548793A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
06/30/2005CA2548657A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
06/30/2005CA2548393A1 Chemokine receptor binding compounds
06/30/2005CA2548388A1 Heterocyclic aspartyl protease inhibitors
06/30/2005CA2547600A1 Novel herbicides
06/30/2005CA2547518A1 Quinolines useful in treating cardiovascular disease
06/30/2005CA2545506A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
06/30/2005CA2545294A1 Tetronic and tetramic acids as inhibitors of beta-secrease
06/29/2005EP1548007A1 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
06/29/2005EP1548005A1 Process for producing 2-substituted pyridine derivative
06/29/2005EP1546391A2 Energy transfer dyes, terminators and use thereof
06/29/2005EP1546158A1 Azole derivatives as antifungal agents
06/29/2005EP1546152A1 Epothilone derivatives
06/29/2005EP1546136A1 Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them
06/29/2005EP1546128A1 Pyrimidine derivatives as selective cox-2 inhibitors
06/29/2005EP1546125A2 Fluorescent labeling reagents with multiple donors and acceptors
06/29/2005EP1546121A1 Substituted triazine kinase inhibitors
06/29/2005EP1546117A2 Protein kinase inhibitors and uses thereof
06/29/2005EP1546116A1 Vanilloid receptor ligands and their use in treatments
06/29/2005EP1546113A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
06/29/2005EP1546111A2 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
06/29/2005EP1546109A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
06/29/2005EP1546107A1 Cox-2 inhibiting pyridine derivatives
06/29/2005EP1546101A1 Naphthyl ether compounds and their use
06/29/2005EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
06/29/2005EP1546097A1 Pyrrole derivatives as antimycobacterial compounds
06/29/2005EP1545543A2 Novel tyrosine kinases inhibitors
06/29/2005EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005CN1633433A N-aroyl cyclic amines
06/29/2005CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/29/2005CN1633416A Nicotinamide derivates useful as p38 inhibitors
06/29/2005CN1633414A Chemical compounds
06/29/2005CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/29/2005CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
06/29/2005CN1631888A Preparation method of agricultural fungicide difenoconazole
06/29/2005CN1631879A Substituted phenyl keto enols as pesticides and herbicides
06/29/2005CN1208334C 2-(1H-1, 2, 4,-triazole-1-radical)-5-furan methylene imidazolidinone derivatives and bactericidal activity
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/29/2005CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
06/29/2005CN1208318C Cycloamine CCR5 receptor antagonists
06/29/2005CN1208047C Self-emulsifying formulation for lipophilic compounds
06/28/2005US6911549 Method of preparing a taxol derivative
06/28/2005US6911478 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
1 ... 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 ... 694